This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merck Patent Gmbh. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Sylvia Dietrich: Innovator in Antibody Technology
Introduction
Sylvia Dietrich is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody technologies. Her work has led to advancements that could have a profound impact on therapeutic applications.
Latest Patents
Sylvia Dietrich holds a patent for a domain-exchanged antibody. This invention provides for a domain-exchanged antibody comprising a light chain (LC) composed of VL-CH3, and a heavy chain (HC) comprising VH-CH3-CH2-CH3. The VL-CH3 of the LC dimerizes with the VH-CH3 of the HC, forming a domain-exchanged LC/HC dimer that includes a CH3LC/CH3HC domain pair. The patent also outlines the means and methods for producing this innovative antibody.
Career Highlights
Sylvia Dietrich is currently employed at Merck Patent GmbH, where she continues to push the boundaries of antibody research. Her expertise and innovative spirit have positioned her as a key player in her field. With a focus on developing cutting-edge solutions, she has made a lasting impact on the biotechnology landscape.
Collaborations
Sylvia has collaborated with notable colleagues, including Stefan Becker and Gordana Wozniak-Knopp. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and innovation.
Conclusion
Sylvia Dietrich's contributions to antibody technology exemplify the spirit of innovation in biotechnology. Her patent for a domain-exchanged antibody showcases her commitment to advancing medical science. Through her work at Merck Patent GmbH and collaborations with esteemed colleagues, she continues to pave the way for future breakthroughs in the field.